Petros Pharmaceuticals Inc Ordinary Shares PTPI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PTPI is a good fit for your portfolio.
News
-
Petros Pharmaceuticals Receives Positive Response from FDA Following Recent Demonstration of Technology Component in Pursuit of OTC Status for STENDRA(R) (avanafil)
-
Petros Pharmaceuticals Reports Positive Results in an Initial Cohort Two-Arm Self-Selection (Phase 2-Equivalent) Study for STENDRA(R) (avanafil) as it Pursues OTC Status
-
Petros Pharmaceuticals Successfully Launches AI Tool In Collaboration with Multi-Billion-Dollar Software Provider
-
Petros Pharmaceuticals Enters into AI Licensing Agreement with Leading Multi-Billion-Dollar Software Provider
-
Thinking about buying stock in Helius Medical Technologies, Peraso, GDS Holdings, Everbridge, or Petros Pharmaceuticals?
-
Thinking about buying stock in Agape ATP, Tempest Therapeutics, Nu Holdings, Bristol-Myers Squibb, or Petros Pharmaceuticals?
-
Thinking about buying stock in Petros Pharmaceuticals, Xpeng Inc, Nukkleus, Cellectar Biosciences, or bluebird bio?
-
Petros Pharmaceuticals Announces Two Upcoming FDA Meetings to Review Progress and Path Forward for STENDRA(R) (avanafil) Rx-to-OTC Switch
Trading Information
- Previous Close Price
- $0.69
- Day Range
- $0.65–0.73
- 52-Week Range
- $0.64–9.54
- Bid/Ask
- $0.66 / $0.69
- Market Cap
- $4.80 Mil
- Volume/Avg
- 231,705 / 854,922
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.26
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on therapeutics that promote medication adherence, tolerability, and preservation of male organic function. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Medical Devices segment. The Prescription Medications segment consists of operations related to vacuum erection devices, which are sold domestically and internationally.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 21
- Website
- https://www.petrospharma.com
Valuation
|
Metric
|
PTPI
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.17 |
Price/Sales | 0.26 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
PTPI
|
|---|---|
Quick Ratio | 1.44 |
Current Ratio | 1.89 |
Interest Coverage | −15.19 |
Quick Ratio
PTPI
Profitability
|
Metric
|
PTPI
|
|---|---|
Return on Assets (Normalized) | −73.84% |
Return on Equity (Normalized) | −189.04% |
Return on Invested Capital (Normalized) | −110.52% |
Return on Assets
PTPI
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Hldvxlrzs | Nvptlc | $70.5 Bil | |
ZTS
| Zoetis Inc Class A | Dcfsvsjmd | Rvx | $70.0 Bil | |
HLN
| Haleon PLC ADR | Twcdsfvnn | Mfsc | $36.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Lsknwnfc | Mvc | $14.3 Bil | |
VTRS
| Viatris Inc | Qpcpdzkc | Xxmp | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Bdhgsrjw | Dxqbg | $12.0 Bil | |
CTLT
| Catalent Inc | Hffrmrcw | Hftsbb | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Ghmysbwc | Typm | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Kybgkfpv | Fhjp | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Hpqgyspy | Gzfvb | $3.4 Bil |